atenolol has been researched along with Chronic Disease in 56 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 9.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "The efficacy and effect on cardiac function of verapamil 120 mg three times a day and atenolol 100 mg once a day, singly and in combination, were evaluated in 15 patients with angina pectoris." | 9.06 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. ( Aitchison, T; Dargie, HJ; Elliott, AT; Findlay, IN; Gillen, G; MacLeod, K, 1987) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 9.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 9.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 8.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "The paper demonstrates that the hydrophilic beta-adrenoblocker (BAB) atenolol is effective in patients with III-IV functional class chronic heart failure (CHF), associated with postinfarction cardiosclerosis (PIC) and dilatational cardiomyopathy (DC)." | 7.73 | [Influence of therapy with atenolol on lethality of patients with chronic heart failure]. ( Aleksinskaia, TV; Syrkin, AL; Syrkina, EA; Vyshinskaia, ID, 2005) |
| "Beta-blockers have many different physiologic effects that could potentially influence the risk of hemorrhagic events in chronic heart failure patients (CHF) on warfarin." | 7.73 | Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. ( Berlowitz, DR; Cunningham, F; Gomez-Caminero, A; Miller, DR; Oliveria, SA; Rothendler, JA, 2006) |
| "The benefits of digoxin in patients with atrial fibrillation may be reduced due to its limited effect on atrioventricular conduction." | 7.69 | [Comparison between digoxin and atenolol in chronic atrial fibrillation]. ( Castillo, G; Lanas, F; Molina, E; Montecinos, A; Salvatici, R; Stockins, B, 1995) |
| "This multicenter, randomized, double-blind, parallel group, placebo lead-in, placebo-controlled study compared the antianginal and anti-ischemic effects of once-daily bedtime dosing of controlled-onset extended-release (COER-24) verapamil to a once-daily morning dosing of amlodipine +/- atenolol in patients with chronic stable angina." | 6.69 | Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. ( Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P, 1999) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 6.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 6.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| "Treatment with atenolol was associated with a marked reduction in maximum treadmill walking distance (mean 356 m) as compared both with placebo (mean 421 m, p less than 0." | 6.66 | Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. ( Lewis, RV; McDevitt, DG; McMurray, J, 1989) |
| " The high incidence of side-effects was probably due to the high dosage used." | 6.65 | Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. ( Van Durme, JP, 1980) |
| "To determine whether, at trough levels, ranolazine improves the total exercise time of patients who have symptoms of chronic angina and who experience angina and ischemia at low workloads despite taking standard doses of atenolol, amlodipine, or diltiazem and to determine times to angina onset and to electrocardiographic evidence of myocardial ischemia, effect on angina attacks and nitroglycerin use, and effect on long-term survival in an open-label observational study extension." | 5.11 | Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. ( Chaitman, BR; Chumakova, G; Kuch, J; Parker, JO; Pepine, CJ; Skettino, SL; Skopal, J; Wang, W; Wolff, AA, 2004) |
| "We investigated whether ranolazine therapy improves exercise-induced angina pectoris and myocardial ischemia compared with placebo or with standard doses of atenolol in patients who had chronic angina and evaluated the effects on hemodynamics at rest and during exercise." | 5.11 | Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris. ( Cocco, G; Pouleur, H; Rousseau, MF; Wolff, AA, 2005) |
| "The efficacy and effect on cardiac function of verapamil 120 mg three times a day and atenolol 100 mg once a day, singly and in combination, were evaluated in 15 patients with angina pectoris." | 5.06 | A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. ( Aitchison, T; Dargie, HJ; Elliott, AT; Findlay, IN; Gillen, G; MacLeod, K, 1987) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 5.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "The effect of propranolol and atenolol on air-flow obstruction in patients with chronic bronchitis was evaluated by means of a double-blind, placebo-controlled cross-over trial." | 5.05 | The effect of beta-blockers on ventilatory function in chronic bronchitis. ( Benatar, SR; Keeton, GR; Ranchod, A, 1982) |
| " The incidence of severe hypertension was significantly lower when nifedipine (odds ratio, 0." | 5.05 | Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis. ( Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V, 2020) |
| "1 The effects of atenolol (50 mg and 100 mg) and oxprenolol (80 mg) on respiratory function were studied in ten patients with angina pectoris or hypertension complicated by chronic airways obstruction." | 5.04 | Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction. ( Chatterjee, SS; Croxson, RS; Cruickshank, JM; Perks, WH, 1978) |
| "Nifedipine, as most calcium-antagonist drugs, is widely used for the treatment of angina pectoris and primary hypertension." | 4.80 | [Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report]. ( Luca, S; Romeo, S, 1999) |
| "The paper demonstrates that the hydrophilic beta-adrenoblocker (BAB) atenolol is effective in patients with III-IV functional class chronic heart failure (CHF), associated with postinfarction cardiosclerosis (PIC) and dilatational cardiomyopathy (DC)." | 3.73 | [Influence of therapy with atenolol on lethality of patients with chronic heart failure]. ( Aleksinskaia, TV; Syrkin, AL; Syrkina, EA; Vyshinskaia, ID, 2005) |
| "Beta-blockers have many different physiologic effects that could potentially influence the risk of hemorrhagic events in chronic heart failure patients (CHF) on warfarin." | 3.73 | Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. ( Berlowitz, DR; Cunningham, F; Gomez-Caminero, A; Miller, DR; Oliveria, SA; Rothendler, JA, 2006) |
| "The benefits of digoxin in patients with atrial fibrillation may be reduced due to its limited effect on atrioventricular conduction." | 3.69 | [Comparison between digoxin and atenolol in chronic atrial fibrillation]. ( Castillo, G; Lanas, F; Molina, E; Montecinos, A; Salvatici, R; Stockins, B, 1995) |
| "Ivabradine has shown anti-ischaemic and anti-anginal activity in a placebo-controlled trial." | 2.71 | Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. ( Bourassa, MG; Ford, I; Fox, K; Tardif, JC; Tendera, M, 2005) |
| "Nifedipine gastrointestinal therapeutic system (GITS) is a once-daily formulation of nifedipine that provides stable plasma concentrations over the entire 24 h dosing interval." | 2.69 | Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina. ( Baird, MG; Bélanger, L; Erne, P; Klinke, P; Kostuk, WJ; Lotan, C; Marmor, A; Motro, M; Palant, A; Sclarowski, S; Stolero, D; Toal, CB; Turpie, A; Weiss, A; Zilberman, A, 1999) |
| "This multicenter, randomized, double-blind, parallel group, placebo lead-in, placebo-controlled study compared the antianginal and anti-ischemic effects of once-daily bedtime dosing of controlled-onset extended-release (COER-24) verapamil to a once-daily morning dosing of amlodipine +/- atenolol in patients with chronic stable angina." | 2.69 | Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. ( Deedwania, PC; Fakouhi, TD; Frishman, WH; Glasser, S; Johnson, M; Stone, P, 1999) |
| "Proteinuria was determined in the course of a three-day collection period at the end of each treatment phase." | 2.68 | [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors]. ( Berger, ED; Braun, N; Erley, CM; Heyne, N; Klass, M; Krämer, D; Risler, T; Wolf, S, 1997) |
| "Proteinuria was assessed by urine sampling at the end of each treatment period." | 2.68 | Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis. ( Berger, E; Braun, N; Erley, CM; Heyne, N; Klass, M; Krämer, D; Risler, T; Wolf, S, 1996) |
| " After a 4 week run-in period on atenolol, patients were randomly allocated to receive either atenolol alone or its combination with nifedipine and then crossed over to the alternative treatment for a further 4 weeks." | 2.67 | Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina. ( Adnams, C; Commerford, P; Meyer, TE, 1993) |
| "Treatment with atenolol was associated with a marked reduction in maximum treadmill walking distance (mean 356 m) as compared both with placebo (mean 421 m, p less than 0." | 2.66 | Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. ( Lewis, RV; McDevitt, DG; McMurray, J, 1989) |
| " However, 2 h after dosing there was a significant prolongation during stress testing in the time to onset of both 1 mm ST depression on the ECG (by 28%) and to angina (by 37%) compared with atenolol alone, but no benefit was apparent by 12 h after dosing." | 2.66 | Slow release nifedipine plus atenolol in chronic stable angina pectoris. ( Challenor, VF; George, CF; Renwick, AG; Waller, DG, 1989) |
| " It improved the side effect profile in some but not all patients." | 2.66 | Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina. ( Adam, G; Akhras, F; Chambers, J; Jackson, G; Ong, ML, 1989) |
| " Treatment was titrated to produce at least a 30% increase in treadmill exercise duration over placebo baseline and then maintained at that dosage for an additional 3 weeks." | 2.66 | Comparison of atenolol and nifedipine in chronic stable angina pectoris. ( Kostis, JB; Narahara, KA; Shapiro, W; Thandroyen, F; Zohman, LR, 1989) |
| " The high incidence of side-effects was probably due to the high dosage used." | 2.65 | Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias. ( Van Durme, JP, 1980) |
| "Hypertension is present in nearly 80% of dialysis patients yet adequately controlled in less than half." | 1.34 | ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients. ( Coyne, DW; Nath, V; Zheng, S, 2007) |
| "Atenolol is a hydrophilic betablocker which is characterized by gastrointestinal absorption, small extent of distribution and renal function-dependent elimination." | 1.34 | Influence of cardiopulmonary bypass on the plasma concentrations of atenolol. ( Auler, JO; Bonafé, WW; Carmona, MJ; Chignalia, AZ; dos Santos, LM; Leite, Fda S; Malbouisson, LM; Santos, SR; Suyama, MJ, 2007) |
| " All patients were treated with atenolol at dosage of 50 mg/die." | 1.28 | [Neurohumoral changes in patients with heart failure treated chronically with beta-blockers]. ( Mattioli, AV; Mattioli, G, 1991) |
| "In patients with congestive heart failure (CHF) sympathetic reflexes are attenuated because of down regulation of beta receptors." | 1.28 | [Hemodynamic effects of the nitroprusside test in chronic congestive heart failure treated with long-term beta blocking therapy]. ( Bettelli, G; Cappello, C; Mattioli, AV; Mattioli, G, 1990) |
| " Thus, plasma half-life after intravenous dosing of atenolol was 6." | 1.27 | Clinical experience with atenolol in patients with chronic liver disease. ( Braun, W; Kirch, W; Mutschler, E; Ohnhaus, EE; Schäfer-Korting, M, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (32.14) | 18.7374 |
| 1990's | 20 (35.71) | 18.2507 |
| 2000's | 16 (28.57) | 29.6817 |
| 2010's | 1 (1.79) | 24.3611 |
| 2020's | 1 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, W | 1 |
| Unger, A | 1 |
| Bauer, SM | 1 |
| Laufer, SA | 1 |
| Bellos, I | 1 |
| Pergialiotis, V | 1 |
| Papapanagiotou, A | 1 |
| Loutradis, D | 1 |
| Daskalakis, G | 1 |
| Medei, EH | 1 |
| Nascimento, JH | 1 |
| Pedrosa, RC | 1 |
| Barcellos, L | 1 |
| Masuda, MO | 1 |
| Sicouri, S | 1 |
| Elizari, MV | 1 |
| de Carvalho, AC | 1 |
| Sever, PS | 1 |
| Poulter, NR | 1 |
| Dahlof, B | 1 |
| Wedel, H | 1 |
| de Silva, R | 1 |
| Fox, KM | 1 |
| Damron, DP | 1 |
| Kanorskiĭ, SG | 1 |
| Zingilevskiĭ, KB | 1 |
| Chaitman, BR | 1 |
| Pepine, CJ | 1 |
| Parker, JO | 1 |
| Skopal, J | 1 |
| Chumakova, G | 1 |
| Kuch, J | 1 |
| Wang, W | 1 |
| Skettino, SL | 1 |
| Wolff, AA | 2 |
| Gratsianskiĭ, NA | 1 |
| Rousseau, MF | 1 |
| Pouleur, H | 1 |
| Cocco, G | 1 |
| Jacob, F | 1 |
| LaBine, BG | 1 |
| Ariza, P | 1 |
| Katz, SA | 1 |
| Osborn, JW | 1 |
| Syrkina, EA | 1 |
| Vyshinskaia, ID | 1 |
| Aleksinskaia, TV | 1 |
| Syrkin, AL | 1 |
| Tardif, JC | 1 |
| Ford, I | 1 |
| Tendera, M | 1 |
| Bourassa, MG | 1 |
| Fox, K | 1 |
| Berlowitz, DR | 1 |
| Miller, DR | 1 |
| Oliveria, SA | 1 |
| Cunningham, F | 1 |
| Gomez-Caminero, A | 1 |
| Rothendler, JA | 1 |
| Leite, Fda S | 1 |
| dos Santos, LM | 1 |
| Bonafé, WW | 1 |
| Chignalia, AZ | 1 |
| Carmona, MJ | 1 |
| Suyama, MJ | 1 |
| Malbouisson, LM | 1 |
| Auler, JO | 1 |
| Santos, SR | 1 |
| Zheng, S | 1 |
| Nath, V | 1 |
| Coyne, DW | 1 |
| Erskine, IA | 1 |
| Mackay, JM | 1 |
| Fox, DP | 1 |
| Lessem, J | 1 |
| Kirch, W | 1 |
| Schäfer-Korting, M | 1 |
| Mutschler, E | 1 |
| Ohnhaus, EE | 1 |
| Braun, W | 1 |
| Chazan, R | 2 |
| Droszcz, W | 1 |
| Doboszyńska, A | 1 |
| Kowalski, J | 1 |
| Barliński, J | 1 |
| Van Durme, JP | 1 |
| Ranchod, A | 1 |
| Keeton, GR | 1 |
| Benatar, SR | 1 |
| Meyer, TE | 1 |
| Adnams, C | 1 |
| Commerford, P | 1 |
| Steffensen, R | 1 |
| Grande, P | 1 |
| Pedersen, F | 1 |
| Haunsø, S | 1 |
| Lanas, F | 1 |
| Salvatici, R | 1 |
| Castillo, G | 1 |
| Montecinos, A | 1 |
| Stockins, B | 1 |
| Molina, E | 1 |
| Erley, CM | 2 |
| Klass, M | 2 |
| Krämer, D | 2 |
| Berger, E | 1 |
| Heyne, N | 2 |
| Braun, N | 2 |
| Wolf, S | 2 |
| Risler, T | 2 |
| Berger, ED | 1 |
| Alpert, JS | 1 |
| Zefirova, GS | 1 |
| Makhneva, IM | 1 |
| Kochergina, II | 1 |
| Plevako, VA | 1 |
| Frishman, WH | 1 |
| Glasser, S | 1 |
| Stone, P | 1 |
| Deedwania, PC | 1 |
| Johnson, M | 1 |
| Fakouhi, TD | 1 |
| Rossetti, E | 1 |
| Fragasso, G | 1 |
| Mellone, R | 1 |
| Vanzulli, A | 1 |
| Del Maschio, A | 1 |
| Chierchia, SL | 2 |
| Luca, S | 1 |
| Romeo, S | 1 |
| Toal, CB | 1 |
| Motro, M | 1 |
| Baird, MG | 1 |
| Klinke, P | 1 |
| Sclarowski, S | 1 |
| Zilberman, A | 1 |
| Marmor, A | 1 |
| Kostuk, WJ | 1 |
| Lotan, C | 1 |
| Weiss, A | 1 |
| Erne, P | 1 |
| Palant, A | 1 |
| Stolero, D | 1 |
| Bélanger, L | 1 |
| Turpie, A | 1 |
| Patrizi, R | 1 |
| Leonardo, F | 1 |
| Pelliccia, F | 1 |
| Galetta, P | 1 |
| Cerquetani, E | 1 |
| Frascà, F | 1 |
| Fini, M | 1 |
| Rosano, GM | 1 |
| Zaglavara, T | 1 |
| Haaverstad, R | 1 |
| Cumberledge, B | 1 |
| Irvine, T | 1 |
| Karvounis, H | 1 |
| Parharidis, G | 1 |
| Louridas, G | 1 |
| Kenny, A | 1 |
| Hugues, FC | 1 |
| Julien, D | 1 |
| Marche, J | 1 |
| Beil, M | 1 |
| Ulmer, WT | 1 |
| Perks, WH | 1 |
| Chatterjee, SS | 1 |
| Croxson, RS | 1 |
| Cruickshank, JM | 1 |
| Melina, D | 1 |
| Guerrera, G | 1 |
| Santoliquido, A | 1 |
| Guerrera, C | 1 |
| Musumeci, V | 1 |
| Nicolò, G | 1 |
| Cataldo, R | 1 |
| Mattioli, AV | 2 |
| Mattioli, G | 2 |
| Williams, AJ | 1 |
| Palmer, KR | 1 |
| Stornello, M | 1 |
| Valvo, EV | 1 |
| Scapellato, L | 1 |
| Sachdev, P | 1 |
| Chee, KY | 1 |
| Cappello, C | 1 |
| Bettelli, G | 1 |
| Bowles, MJ | 1 |
| Smith, L | 1 |
| Glover, DR | 1 |
| Mader, SL | 1 |
| Mackall, JA | 1 |
| Emert, MP | 1 |
| Kohli, RS | 1 |
| Lahiri, A | 2 |
| Raftery, EB | 2 |
| Lewis, RV | 1 |
| McMurray, J | 1 |
| McDevitt, DG | 1 |
| Challenor, VF | 1 |
| Waller, DG | 1 |
| Renwick, AG | 1 |
| George, CF | 1 |
| Chambers, J | 1 |
| Ong, ML | 1 |
| Akhras, F | 1 |
| Adam, G | 1 |
| Jackson, G | 1 |
| Shapiro, W | 1 |
| Narahara, KA | 1 |
| Kostis, JB | 1 |
| Thandroyen, F | 1 |
| Zohman, LR | 1 |
| Rodrigues, EA | 1 |
| Lawrence, JD | 1 |
| Dasgupta, P | 1 |
| Hains, AD | 1 |
| Wilkinson, PR | 1 |
| Maltz, MB | 1 |
| Dymond, DS | 1 |
| Nathan, AW | 1 |
| Camm, AJ | 1 |
| Findlay, IN | 1 |
| MacLeod, K | 1 |
| Gillen, G | 1 |
| Elliott, AT | 1 |
| Aitchison, T | 1 |
| Dargie, HJ | 1 |
| Wu, SC | 1 |
| Secchi, MB | 1 |
| Mancarella, S | 1 |
| Bettazzi, L | 1 |
| Civelli, M | 1 |
| Cirò, A | 1 |
| Oltrona, L | 1 |
| Folli, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock (ES-FISH)[NCT03437369] | Phase 4 | 22 participants (Anticipated) | Interventional | 2018-05-31 | Not yet recruiting | ||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for atenolol and Chronic Disease
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease | 2020 |
[Atenolol in the treatment of patients with airway obstruction].
Topics: Adrenergic beta-Antagonists; Airway Obstruction; Airway Resistance; Animals; Arrhythmias, Cardiac; A | 1998 |
[Edema and skin ulcers of the lower limbs as a collateral effect of nifedipine. A clinical case report].
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chronic Disease; | 1999 |
29 trials available for atenolol and Chronic Disease
| Article | Year |
|---|---|
Chronic hypertension in pregnancy.
Topics: Atenolol; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; F | 2002 |
Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Topics: Acetanilides; Adrenergic beta-Antagonists; Aged; Amlodipine; Angina Pectoris; Atenolol; Calcium Chan | 2004 |
Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Topics: Acetanilides; Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Ateno | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzazepines; Cardiovascular Agents; Chronic | 2005 |
Combined therapy with Ca-antagonists and beta-adrenergic receptor blocking agents in chronic stable angina.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Drug Therapy, Combination; | 1984 |
Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atenolol; Chronic Disease; Clinical Trials as Topic; Disopyramide; Double-Blin | 1980 |
The effect of beta-blockers on ventilatory function in chronic bronchitis.
Topics: Adult; Atenolol; Bronchitis; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Humans; | 1982 |
Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Topics: Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Double-Blin | 1993 |
Effects of atenolol and diltiazem on exercise tolerance and ambulatory ischaemia.
Topics: Adult; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Diltiazem; Double-Bl | 1993 |
Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonist | 1996 |
[Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agent | 1997 |
Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzimidazoles; Calcium Channel Blockers; Ch | 1998 |
Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Amlodipine; Angina Pectoris; Atenolol; Calcium | 1999 |
Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; | 1999 |
Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease | 2001 |
[Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease (author's transl)].
Topics: Adult; Aged; Airway Resistance; Atenolol; Blood Pressure; Bronchi; Chronic Disease; Clinical Trials | 1977 |
Comparison of atenolol and oxprenolol in patients with angina or hypertension and co-existent chronic airways obstruction.
Topics: Adult; Airway Obstruction; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trials as Topic; Dou | 1978 |
Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria.
Topics: Atenolol; Blood Pressure; Chlorthalidone; Chronic Disease; Diabetic Nephropathies; Diabetic Retinopa | 1991 |
Pharmacological characterization of tardive akathisia.
Topics: Administration, Oral; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Arousal; Atenolol; Benztr | 1990 |
Randomised, double-blind, three-way cross-over study of dilevalol 200 and 400 mg and atenolol 100 mg once-daily in patients with chronic stable angina pectoris.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Angina Pectoris; Atenolol; Blood Pressure; | 1990 |
Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Do | 1986 |
Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
Topics: Adrenergic beta-Agonists; Aged; Atenolol; Atrial Fibrillation; Chronic Disease; Digitalis Glycosides | 1989 |
Slow release nifedipine plus atenolol in chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Delayed-Action Preparations; Double-Blind M | 1989 |
Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Benzeneacetamides; | 1989 |
Comparison of atenolol and nifedipine in chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Chronic Disease; Double-Blind Method; Electrocardiography; Exercise | 1989 |
Comparison of bevantolol and atenolol in chronic stable angina.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Chronic Disease; Clinical Trial | 1988 |
A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Clinical Trials as Topic; Drug Adminis | 1987 |
A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-B | 1987 |
Beta-blocker versus diuretic for control of the blood pressure response to stress in hypertensive patients.
Topics: Adult; Amiloride; Atenolol; Chronic Disease; Drug Combinations; Female; Heart Rate; Humans; Hydrochl | 1986 |
24 other studies available for atenolol and Chronic Disease
| Article | Year |
|---|---|
Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases.
Topics: Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cyclic Nucleotide | 2017 |
Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atenolol; Calcium Channels, L-Type; Chagas Cardi | 2008 |
Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Atorvastatin; Cholesterol; Chronic Dise | 2009 |
Angina: Ivabradine for treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzazepines; Chroni | 2009 |
[Comparative effects of amiodarone, diltiazem, and atenolol on results of electrical cardioversion in patients with chronic atrial fibrillation].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Chronic Disease; Dil | 2002 |
[Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Atenolol; Cardiovascular Age | 2004 |
Renal denervation causes chronic hypotension in rats: role of beta1-adrenoceptor activity.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Autonomic De | 2005 |
[Influence of therapy with atenolol on lethality of patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Atenolol; Chronic Disease; Echocardiography; Electrocardiography, Ambul | 2005 |
Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atenolol | 2006 |
Influence of cardiopulmonary bypass on the plasma concentrations of atenolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiopulmonary Bypass; Chronic D | 2007 |
ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Anti | 2007 |
Monitoring patients on long-term drug therapy for genotoxic effects.
Topics: Atenolol; Azathioprine; Cells, Cultured; Chlorpropamide; Chronic Disease; Drug-Related Side Effects | 1984 |
Clinical experience with atenolol in patients with chronic liver disease.
Topics: Administration, Oral; Adult; Atenolol; Chronic Disease; Female; Humans; Injections, Intravenous; Kid | 1983 |
[Usefulness of atenolol in the treatment of patients with chronic bronchitis or bronchial asthma].
Topics: Adult; Aged; Asthma; Atenolol; Blood Pressure; Bronchitis; Chronic Disease; Depression, Chemical; Fe | 1983 |
[Comparison between digoxin and atenolol in chronic atrial fibrillation].
Topics: Adult; Aged; Analysis of Variance; Atenolol; Atrial Fibrillation; Blood Pressure; Chronic Disease; C | 1995 |
[An apathetic form of thyrotoxicosis].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Atenolol; Chronic Disease; Diagnosis, Differential; | 1998 |
Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Chronic Disease; Contrast Media; Coronary Angiog | 1999 |
Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; | 2002 |
[Effects of beta blockaders on ventilatory function in chronic bronchitis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Bronchitis; Chronic Disease; Coronary Dise | 1979 |
[Efficacy of the combination of nicardipine-enalapril and atenolol in severe hypertension secondary to chronic renal disease].
Topics: Adult; Atenolol; Chronic Disease; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension | 1992 |
[Neurohumoral changes in patients with heart failure treated chronically with beta-blockers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Chronic Disease; Digitalis; Diuretics; Drug Eval | 1991 |
Severe constipation as the presenting complaint of phaeochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Atenolol; Chronic Disease; Constipation; Fe | 1991 |
[Hemodynamic effects of the nitroprusside test in chronic congestive heart failure treated with long-term beta blocking therapy].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Chronic Disease; Female; Heart Failure; Heart Ra | 1990 |
Hyperadrenergic orthostatic intolerance as a result of postpartum blood loss.
Topics: Adult; Atenolol; Chronic Disease; Female; Fludrocortisone; Fluid Therapy; Humans; Hypotension, Ortho | 1990 |